LLY

Eli Lilly (LLY)

Eli Lilly and Co

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:LLY

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/05/22	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/05/22	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/05/22	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/05/22	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/05/22	05 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/05/22	04 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/05/21	21 : 00	PR Newswire (US)	More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure	NYSE:LLY	Eli Lilly and Co
2024/05/21	20 : 18	IH Market News	CalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More News	NYSE:LLY	Eli Lilly and Co
2024/05/16	19 : 45	PR Newswire (US)	With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin	NYSE:LLY	Eli Lilly and Co
2024/05/15	21 : 00	PR Newswire (US)	Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer	NYSE:LLY	Eli Lilly and Co
2024/05/10	05 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LLY	Eli Lilly and Co
2024/05/07	00 : 32	PR Newswire (US)	Lilly Declares Second-Quarter 2024 Dividend	NYSE:LLY	Eli Lilly and Co
2024/04/30	22 : 07	IH Market News	Futures Pointing To Roughly Flat Open On Wall Street	NYSE:LLY	Eli Lilly and Co
2024/04/30	20 : 59	IH Market News	U.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate Decision	NYSE:LLY	Eli Lilly and Co
2024/04/30	20 : 55	IH Market News	HSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in Earnings	NYSE:LLY	Eli Lilly and Co
2024/04/30	19 : 45	PR Newswire (US)	Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum	NYSE:LLY	Eli Lilly and Co
2024/04/17	19 : 15	PR Newswire (US)	Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity	NYSE:LLY	Eli Lilly and Co
2024/04/16	23 : 00	PR Newswire (US)	Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement	NYSE:LLY	Eli Lilly and Co
2024/04/03	20 : 12	IH Market News	Cal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and More	NYSE:LLY	Eli Lilly and Co
2024/03/12	05 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/03/12	05 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/03/11	05 : 00	PR Newswire (US)	More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study	NYSE:LLY	Eli Lilly and Co
2024/03/08	20 : 45	PR Newswire (US)	U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab	NYSE:LLY	Eli Lilly and Co
2024/03/07	22 : 00	PR Newswire (US)	Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care	NYSE:LLY	Eli Lilly and Co
2024/03/06	07 : 00	PR Newswire (US)	Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting	NYSE:LLY	Eli Lilly and Co
2024/02/22	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/02/22	06 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/02/22	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/02/22	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co